恶性疟疾

增强化学发光法标记的DNA探针诊断恶性疟疾

Evaluation of ECL labelled DNA probe for diagnosis of falciparum malaria

青蒿琥酯治疗在马里共和国的恶性疟疾321例

Artesunate for 321 patients with falciparum malaria in the Republic of Mali

恶性疟疾重组质粒pPF（14）DNA探针的制备

The Preparation of Recombinant Clone pPF_ ( 14 ) DNA Probes

以青蒿素为基础的联合药物疗法（ACTs）被认为是目前治疗恶性疟疾的最有效方法。

Artemisinin-based combination therapies ( ACTs ) were recommended to be the most effective therapies for the first-line treatment of uncomplicated falciparum malaria .

方法：采用青蒿琥酯片3天、5天和7天疗程总量400mg、600mg和800mg，治疗恶性疟疾90例。

Methods : A randomized controlled study on the treatment of 90 uncomplicated falciparum malaria patients was carried out with 400 mg of artesunate tablet as a total dose over 3 days , 600 mg over 5 days and 800 mg over 7 days .

肺结核合并恶性疟疾的临床特点与治疗分析

Clinical characteristics and treatment of pulmonary tuberculosis complicated with pernicious malaria

目的观察恶性疟疾肺部X线的改变。

Objective To observe the pulmonary X-ray changes of malignant malaria .

温州口岸8例输入性恶性疟疾的流行病学调查

The Epidemiological Investigation on Eight Malignant Malaria Cases at Wenzhou Port

青蒿素片加复方硝喹治疗恶性疟疾的效果

Effects of Tablet Qinghaosu Plus Nitroquine Compound on Falciparum Malaria

在刚果所见到的恶性疟疾（260例的临床分型及治疗）

Malignant Malaria Seen in Congo ( Clinical Analysis of 260 Cases )

恶性疟疾144例临床分析

Clinical analysis of 144 cases of malignant malaria in Yunnan

针刺治疗非洲恶性疟疾致疼痛110例

Acupuncture Treatment of 110 Cases of Pain Induced by African Pernicious Malaria

中国人和非洲人恶性疟疾的临床特征分析。

Clinical analysis of characteristics of Chinese and African falciparum malaria patients .

对该地区恶性疟疾的流行发病特点和治疗以及恶性疟疾发病原理进行了讨论。

The epidemiologic feature , treatment and pathogenesis of malignant malaria were discussed .

聚合酶链反应用于恶性疟疾诊断初步研究

Preliminary study on the diagnosis of Plasmodium falciparum infections by polymerase chain reaction

恶性疟疾肺部X线征象（附86例分析）

Pulmonary X-ray Signs of Malignant Malaria ( An Analysis of 86 Cases )

国产双氢青蒿素哌喹片治疗非洲恶性疟疾疗效观察

Efficacy of dihydroartemisinin-piperaquine tablets made in China in treatment of falciparum malaria in Africa

目的观察国产双氢青蒿素哌喹片治疗恶性疟疾的临床效果。

Observation on the therapeutic effect of Quinimax on Plasmodium falciparum malaria in Africa ;

45例重症恶性疟疾临床分析

Clinical analysis of 45 severe Plasmodium falciparum malaria

目的观察双氢青蒿素与甲氟喹联用治疗急性无并发症恶性疟疾的临床疗效。

Objective To evaluate the clinical efficacy of dihydroartemisinin & mefloquine on acute uncomplicated falciparum malaria .

咯萘啶针剂与防疟2号片及伯喹联用治疗恶性疟疾的效果

Effects of combined use of pyronaridine injection and tablet No.2 malaria prophylaxis and primaquine on falciparum malaria

临床上主要用于恶性疟疾的治疗，且疗效显著。

Clinically , it is approved for the treatment of pernicious malaria and has an excellent efficacy .

它们是针对作为最致命形式疟疾的恶性疟疾的最有效治疗手段。

They are the most effective treatment for falciparum malaria , the most deadly form of malaria .

三亚市低疟区一起恶性疟疾点状爆发的调查处理

Survey and treatment of a sporadic outbreak of falciparum malaria in a low endemic areas of Sanya City

但2009年欧洲区域首次无任何一例恶性疟疾病例报告。

For the first time not a single case of falciparum malaria was reported in the European Region in2009 .

〔目的〕通过对输入性恶性疟疾病例的流行病学调查，掌握温州口岸恶性疟疾流行现状及特点，为口岸恶性疟疾的预防控制提供依据。

Objective To understand the spreading conditions of malignant malaria and provide foundations of prevention and control at Wenzhou ports .

世卫组织的治疗政策是，应采用青蒿素联合治疗药物来治疗一切无并发症的恶性疟疾病例。

WHO 's treatment policy is to treat all cases of uncomplicated falciparum malaria with artemisinin combination therapy ( ACTs ) .

复方蒿甲醚和组份之一本芴醇两种剂型治疗恶性疟疾临床对比试验

Clinical comparative trial of co - artemether , and one of its components benflumetol ( two formulations ) in treating falciparum malaria

青蒿素及其衍生物是一类活性很强的抗疟疾药物，主要用于治疗对氯喹耐药的恶性疟疾。

Artemisinin and its derivatives are a class of highly active anti-malarial drugs , primarily for the treatment of chloroquine-resistant falciparum malaria .

青蒿琥酯和青蒿素抗肿瘤作用及其机制的初步研究青蒿琥酯治疗在马里共和国的恶性疟疾321例

Analyzing the mechanisms related with anti-cancer of artesunate and artemisinin Artesunate for 321 patients with falciparum malaria in the Republic of Mali